This can help improve time in range overnight and during the day. Expanded age and weight indications for very small and very large insulin requirements. A Temp Basal Rate option to personalize insulin delivery for changing needs during automation. The only system with an extended bolus, up to eight hours, during automated insulin delivery. If glucose is predicted to be above 180 mg/dL, an AutoBolus will be delivered. Proven results with Tandem Diabetes Glyco Care dosage automated insulin delivery systems. Uses a narrower and lower range of treatment values to help guard against lows and highs while sleeping. Uses a narrower and higher range of treatment values to help guard against lows during activity. Whether you want the tiny and powerful Tandem Mobi, or the all-in-one t:slim X2 pump, you can choose the automated insulin delivery system to fit your lifestyle. A Tandem Diabetes Glyco Care benefits Specialist will help you get started. I authorize Tandem Diabetes Care, Inc. and its representatives to contact me via email, text or phone (including using an automatic dialing system or artificial or prerecorded voice) regarding Tandem products, services and programs.
I also understand that my carrier's message and data rates may apply, and that my consent to this contact is not required for the purchase of Tandem products or services. I certify that I am at least eighteen (18) years of age and that I have read, understand, and agree to this HIPAA Authorization. Test drive the easy-to-use interfaces of either the Tandem Mobi system or t:slim X2 insulin pump, with no obligation. See what people are saying about the Tandem automated insulin delivery and how it is changing their lives. Choose from a variety of cannula materials, tubing lengths, and insertion angles to fit all your needs. Our mobile and cloud-based applications are designed to help you better manage your diabetes. Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here. A bolus is a single, large dose of medicine. If glucose values are predicted to be above 180 mg/dL Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value.
Note: Studies were conducted using a t:slim X2 insulin pump with Control-IQ technology and a Dexcom G6 sensor. 1. Beck RW, et al. 2. Akturk HK, et al. 3. Messer LH, Breton M. Diabetes Technol Ther. Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, Glyco Careglucose metabolism for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater. X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin.
The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater. CGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. 1 diabetes mellitus in persons 2 years of age and greater and Glyco Careglucose metabolism of type 2 diabetes mellitus in persons 18 years of age and greater. 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. CGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events.